Abstract:A unique mutation in LRP5 is associated with high bone mass in man. Transgenic mice expressing this LRP5 mutation have a similar phenotype with high bone mass and enhanced strength. These results underscore the importance of LRP5 in skeletal regulation and suggest targets for therapies for bone disease. A mutation (G171V) in the low-density lipoprotein receptor related protein 5 (LRP5) has been associated with high bone mass (HBM) in two independent human kindreds. To validate the role of the, mutation, several lines of transgenic mice were created expressing either the human LRP5 G171V substitution or the wildtype LRP5 gene in bone. Volumetric bone mineral density (vBMD) analysis by pQCT showed dramatic increases in both total vBMD (30-55%) and trabecular vBMD (103-250%) of the distal femoral metaphysis and increased cortical size of the femoral diaphysis in mutant G171V transgenics at 5, 9, 17, 26, and 52 weeks of age (p < 0.01 for all). In addition, high-resolution microcomputed tomography (microCT) analysis of the distal femorae and lumbar vertebrae revealed an increase (110-232%) in trabecular bone volume fraction caused by both increased trabecular number (41-74%) and increased trabecular thickness (34-46%; p < 0.01 for all) in the mutant G171V mice. The increased bone mass was associated with significant increases in vertebral compressive strength (80-140%) and the increased cortical size with significant increases in femoral bending strength (50-130%). There were no differences in osteoclast number at 17 weeks of age. However, compared with littermate controls, the mutant G171V transgenic mice showed an increase in actively mineralizing bone surface, enhanced alkaline phosphatase staining in osteoblasts, and a significant reduction in the number of TUNEL-positive osteoblasts and osteocytes. These results suggest that the increased bone mineral density in mutant G171V mice was caused by increased numbers of active osteoblasts, which could in part be because of their increased functional lifespan. While slight bone anabolic activity was observed from overexpression of the wildtype LRP5 gene, it is clear that the G171V mutation, rather than overexpression of the receptor itself, is primarily responsible for the dramatic HBM bone effects. Together, these findings establish the importance of this novel and unexpected role of a lipoprotein receptor in regulating bone mass and afford a new model to explore LRP5 and its recent association with Wnt signaling in bone biology.

Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass

LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development

LRP5, Bone Mass Polymorphisms and Skeletal Disorders

Oncogenic Osteomalacia in Renal Cell Carcinoma: a Case Report and Literature Review

Six Novel Missense Mutations in the LDL Receptor-Related Protein 5 (LRP5) Gene in Different Conditions with an Increased Bone Density

LRP5 Variant Without Pseudoglioma in a Young Man With Fragility Fractures

Characterization of A Relatively Malignant Form of Osteopetrosis Caused by A Novel Mutation in the Plekhm1 Gene

Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy.

The Genetics of Low-Density Lipoprotein Receptor-Related Protein 5 in Bone: A Story of Extremes

Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone with Giant Cell Tumors.

High bone mass in mice expressing a mutant LRP5 gene.

Clinical Characteristics and Pathogenic Gene Identification in Chinese Patients with Paget's Disease of Bone

Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene

The A242t Mutation In The Low-Density Lipoprotein Receptor-Related Protein 5 Gene In One Chinese Family With Osteosclerosis

Early‐onset osteoporosis: Rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen

Identification of a Novel Splicing Mutation and Genotype-Phenotype Correlations in Rare PLS3-related Childhood-Onset Osteoporosis

Lrp4 In Osteoblasts Suppresses Bone Formation And Promotes Osteoclastogenesis And Bone Resorption

Multifocal heterotopic ossification in a man with germline variants of LIM Mineralization Protein-1 (LMP-1)

The Pathogenesis of Ossification of the Posterior Longitudinal Ligament.

Osteoporosis-pseudoglioma Syndrome, a Disorder Affecting Skeletal Strength and Vision, is Assigned to Chromosome Region 11Q12-13.

High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes